September 24, 2024 11:45 ET | Source: Transgene S.A. Transgene S.A.
Rapport Semestriel 2024
Pièce jointe
TG-MVA builds on Transgene’s expertise in MVA (Modified Vaccinia Ankara) viral vectors, which are well established in smallpox vaccines development Extensive data with TG-MVACEF and TG-MVACL...
Transgene’s Combined General Meeting of May 22, 2026